This suggests an improved effectiveness of MCO to not only remove small toxic molecules (<0.5kD), but also middle-sized molecules and pro-inflammatory mediators, such as TNF-α, interleukins, β-2-microglobulin, and others (76), compared to the conventional HF hemodialyzers. This evidence concerns the gene TNF and hydrops fetalis.